BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Perrino C, Ferdinandy P, Bøtker HE, Brundel BJJM, Collins P, Davidson SM, den Ruijter HM, Engel FB, Gerdts E, Girao H, Gyöngyösi M, Hausenloy DJ, Lecour S, Madonna R, Marber M, Murphy E, Pesce M, Regitz-Zagrosek V, Sluijter JPG, Steffens S, Gollmann-Tepeköylü C, Van Laake LW, Van Linthout S, Schulz R, Ytrehus K. Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart. Cardiovasc Res 2021;117:367-85. [PMID: 32484892 DOI: 10.1093/cvr/cvaa155] [Cited by in Crossref: 18] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Gerdts E, Sudano I, Brouwers S, Borghi C, Bruno RM, Ceconi C, Cornelissen V, Diévart F, Ferrini M, Kahan T, Løchen ML, Maas AHEM, Mahfoud F, Mihailidou AS, Moholdt T, Parati G, de Simone G. Sex differences in arterial hypertension. Eur Heart J 2022:ehac470. [PMID: 36136303 DOI: 10.1093/eurheartj/ehac470] [Reference Citation Analysis]
2 Reue K, Wiese CB. Illuminating the Mechanisms Underlying Sex Differences in Cardiovascular Disease. Circ Res 2022;130:1747-62. [PMID: 35679362 DOI: 10.1161/CIRCRESAHA.122.320259] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
3 van Ham WB, Kessler EL, Oerlemans MI, Handoko ML, Sluijter JP, van Veen TA, den Ruijter HM, de Jager SC. Clinical Phenotypes of Heart Failure With Preserved Ejection Fraction to Select Preclinical Animal Models. JACC: Basic to Translational Science 2022. [DOI: 10.1016/j.jacbts.2021.12.009] [Reference Citation Analysis]
4 Raparelli V, Nocella C, Proietti M, Romiti GF, Corica B, Bartimoccia S, Stefanini L, Lenzi A, Viceconte N, Tanzilli G, Cammisotto V, Pilote L, Cangemi R, Basili S, Carnevale R; EVA Collaborators. Testosterone-to-estradiol ratio and platelet thromboxane release in ischemic heart disease: the EVA project. J Endocrinol Invest 2022. [PMID: 35262860 DOI: 10.1007/s40618-022-01771-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Geng YJ, Madonna R, Hermida RC, Smolensky MH. Pharmacogenomics and circadian rhythms as mediators of cardiovascular drug-drug interactions. Curr Res Pharmacol Drug Discov 2021;2:100025. [PMID: 34909660 DOI: 10.1016/j.crphar.2021.100025] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Pinto AR. Matricellular Proteins As Critical Regulators of Fibrosis. Circ Res 2021;129:1036-8. [PMID: 34762503 DOI: 10.1161/CIRCRESAHA.121.320273] [Reference Citation Analysis]
7 Lecour S, Andreadou I, Bøtker HE, Davidson SM, Heusch G, Ruiz-Meana M, Schulz R, Zuurbier CJ, Ferdinandy P, Hausenloy DJ; the European Union-CARDIOPROTECTION COST ACTION CA16225. IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action. Basic Res Cardiol 2021;116:52. [PMID: 34515837 DOI: 10.1007/s00395-021-00893-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lecour S, Du Pré BC, Bøtker HE, Brundel BJJM, Daiber A, Davidson SM, Ferdinandy P, Girao H, Gollmann-Tepeköylü C, Gyöngyösi M, Hausenloy DJ, Madonna R, Marber M, Perrino C, Pesce M, Schulz R, Sluijter JPG, Steffens S, Van Linthout S, Young ME, Van Laake LW. Circadian rhythms in ischaemic heart disease. Key aspects for preclinical and translational research: Position paper of the ESC Working Group on Cellular Biology of the Heart. Cardiovasc Res 2021:cvab293. [PMID: 34505881 DOI: 10.1093/cvr/cvab293] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Kumar A, Boovarahan SR, Prem PN, Ramanathan M, Chellappan DR, Kurian GA. Evaluating the effects of carbon monoxide releasing molecule-2 against myocardial ischemia-reperfusion injury in ovariectomized female rats. Naunyn Schmiedebergs Arch Pharmacol 2021. [PMID: 34338837 DOI: 10.1007/s00210-021-02129-8] [Reference Citation Analysis]
10 Pesce M, Agostoni P, Bøtker HE, Brundel B, Davidson SM, De Caterina R, Ferdinandy P, Girao H, Gyöngyösi M, Hulot JS, Lecour S, Perrino C, Schulz R, Sluijter JPG, Steffens S, Tancevski I, Gollmann-Tepeköylü C, Tschöpe C, van Linthout S, Madonna R. COVID-19 related cardiac complications - from clinical evidences to basic mechanisms. Opinion paper of the ESC Working Group on Cellular Biology of the Heart. Cardiovasc Res 2021:cvab201. [PMID: 34117887 DOI: 10.1093/cvr/cvab201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
11 Davidson SM, Padró T, Bollini S, Vilahur G, Duncker DJ, Evans PC, Guzik T, Hoefer IE, Waltenberger J, Wojta J, Weber C. Progress in cardiac research - from rebooting cardiac regeneration to a complete cell atlas of the heart. Cardiovasc Res 2021:cvab200. [PMID: 34114614 DOI: 10.1093/cvr/cvab200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
12 Figtree GA, Vernon ST. Coronary artery disease patients without standard modifiable risk factors (SMuRFs)- a forgotten group calling out for new discoveries. Cardiovasc Res 2021;117:e76-8. [PMID: 34037711 DOI: 10.1093/cvr/cvab145] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Angeloni M, Thievessen I, Engel FB, Magni P, Ferrazzi F. Functional genomics meta-analysis to identify gene set enrichment networks in cardiac hypertrophy. Biol Chem 2021;402:953-72. [PMID: 33951759 DOI: 10.1515/hsz-2020-0378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Lassen TR, Hjortbak MV, Hauerslev M, Tonnesen PT, Kristiansen SB, Jensen RV, Bøtker HE. Influence of strain, age, origin, and anesthesia on the cardioprotective efficacy by local and remote ischemic conditioning in an ex vivo rat model. Physiol Rep 2021;9:e14810. [PMID: 33818005 DOI: 10.14814/phy2.14810] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Cignarella A, Fadini GP, Bolego C, Trevisi L, Boscaro C, Sanga V, Seccia TM, Rosato A, Rossi GP, Barton M. Clinical Efficacy and Safety of Angiogenesis Inhibitors: Sex Differences and Current Challenges. Cardiovasc Res 2021:cvab096. [PMID: 33739385 DOI: 10.1093/cvr/cvab096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Lønnebakken MT. The risk of no risk in STEMI. Lancet 2021;397:1039-40. [PMID: 33711295 DOI: 10.1016/S0140-6736(21)00375-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Herrera-Zelada N, Zuñiga-Cuevas U, Ramirez-Reyes A, Lavandero S, Riquelme JA. Targeting the Endothelium to Achieve Cardioprotection. Front Pharmacol 2021;12:636134. [PMID: 33603675 DOI: 10.3389/fphar.2021.636134] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
18 Shin J, Ham D, Paik HY, Shin S, Joung H. Gender Differences in the Risk of Ischemic Heart Disease According to Healthcare Utilization and Medication Adherence among Newly Treated Korean Hypertensive Patients. Int J Environ Res Public Health 2021;18:1274. [PMID: 33572632 DOI: 10.3390/ijerph18031274] [Reference Citation Analysis]
19 Penna C, Femminò S, Alloatti G, Brizzi MF, Angelone T, Pagliaro P. Extracellular Vesicles in Comorbidities Associated with Ischaemic Heart Disease: Focus on Sex, an Overlooked Factor. J Clin Med 2021;10:327. [PMID: 33477341 DOI: 10.3390/jcm10020327] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Svoboda LK, Wang K, Jones TR, Colacino JA, Sartor MA, Dolinoy DC. Sex-Specific Alterations in Cardiac DNA Methylation in Adult Mice by Perinatal Lead Exposure. Int J Environ Res Public Health 2021;18:E577. [PMID: 33445541 DOI: 10.3390/ijerph18020577] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
21 Diaconu R, Donoiu I, Mirea O, Bălşeanu TA. Testosterone, cardiomyopathies, and heart failure: a narrative review. Asian J Androl 2021;23:348-56. [PMID: 33433530 DOI: 10.4103/aja.aja_80_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
22 Bienvenu LA, Noonan J, Wang X, Peter K. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities. Cardiovasc Res 2020;116:2197-206. [PMID: 33063089 DOI: 10.1093/cvr/cvaa284] [Cited by in Crossref: 23] [Cited by in F6Publishing: 62] [Article Influence: 11.5] [Reference Citation Analysis]
23 Silvis MJM, Kaffka Genaamd Dengler SE, Odille CA, Mishra M, van der Kaaij NP, Doevendans PA, Sluijter JPG, de Kleijn DPV, de Jager SCA, Bosch L, van Hout GPJ. Damage-Associated Molecular Patterns in Myocardial Infarction and Heart Transplantation: The Road to Translational Success. Front Immunol 2020;11:599511. [PMID: 33363540 DOI: 10.3389/fimmu.2020.599511] [Cited by in Crossref: 5] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
24 Golforoush P, Yellon DM, Davidson SM. Mouse models of atherosclerosis and their suitability for the study of myocardial infarction. Basic Res Cardiol 2020;115:73. [PMID: 33258000 DOI: 10.1007/s00395-020-00829-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
25 Schulz R, Andreadou I, Hausenloy DJ, Ferdinandy P. Risk factors, co-morbidities, and co-medications in cardioprotection: Importance for translation. Br J Pharmacol 2020;177:5249-51. [PMID: 33219717 DOI: 10.1111/bph.15294] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
26 Lønnebakken MT. Cardiometabolic Risk Factors and Coronary Artery Disease in Women. J Womens Health (Larchmt) 2020;29:1489-90. [PMID: 32960130 DOI: 10.1089/jwh.2020.8755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]